December 17, 2018

Genetics Signatures (ASX:GSS) CE-IVD Mark for Respiratory Pathogen Detection Kit

October 28, 2019

Genetic Signatures Ltd Completes $35m Placement

Company has raised $35m through a placement to institutional and sophisticated investors. Cornerstone investors include Perennial Value Management and Regal Funds Management plus a large global funds manager. The placement at $0.98 per share was a 9.3% discount to last closing price.

View Announcement

Non-Executive Director Retirement

Non-executive director, Mr Phillip Isaacs, has advised he will retire from the Board t the conclusion of the 2019 Annual General Meeting

View Announcement

$A2.1m R&D Rebate Received

Company received its rebate from the Australia Tax Office for the 2019 financial year

View Announcement

November 19, 2019

Successful Completion of Share Purchase Plan

SPP closed on 15 November 2019 significantly oversubscribed.

View Announcement